Morgan Stanley Reiterates Overweight on Exelon, Maintains $47 Price Target
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst David Arcaro has reiterated an Overweight rating on Exelon (NASDAQ:EXC) and maintained a $47 price target.

July 21, 2023 | 2:22 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Exelon's stock rating has been reiterated as Overweight by Morgan Stanley, with a maintained price target of $47.
The reiteration of an Overweight rating by a major financial institution like Morgan Stanley generally indicates a positive outlook for the company's stock. This could potentially lead to an increase in investor confidence and a short-term rise in the stock price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100